Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch
It isn't just obesity — chronic liver disease is also an increasing problem in the U.S., for new patient groups.
Chronic disease is, by its very definition, omnipresent. But changes year to year have the potential to make certain conditions into flaming-red targets for researchers and drugmakers. This year was one for obesity, marked by new — and for the first time, highly effective — weight loss drugs that demonstrated other health benefits.
But whether that wave of interest will persist into the new year, or transfer to some other condition — maybe some liver diseases that are troublingly on the rise — is what we’re asking our crystal ball. Here are three predictions for what’s to come in the world of chronic disease in 2024:
What's Your Reaction?
